Erba Diagnostics, Inc. Receivables Turnover Ratio (IVD), from the first quarter 2015 to the first quarter 2012 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Erba Diagnostics, Inc.  (IVD)
 

Erba Diagnostics Accounts Receivables Turnover Ratio from the first quarter 2015 to the first quarter 2012

Quarterly Results, Trends, Rankings, Statistics


Erba Diagnostics, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2015 to a ratio of 3.13, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Erba Diagnostics in Mar 31 2015 quarter, has decreased to 117 days, compared to 118 days, in the Dec 31 2014 quarter.

If we take a look into Healthcare sector 305 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2015 from 932 to 3229.

What is Receivable Turnover Ratio?
What is Erba Diagnostics, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IVD Receivables Turnover Ratio (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2012)
I. Quarter
Y / Y Receivable Change 6.91 % 32.83 % 43.44 % 46.38 % 1413.02 %
Y / Y Revenue Change 13.57 % 43.42 % 59.36 % 72.36 % 3.36 %
Receivable Turnover Ratio (TTM) 3.13 3.1 3.05 2.98 2.81
IVD's Total Ranking # 3229 # 932 # 0 # #
Accounts Receivable average collection period days 117 118 120 122 130
Seq. Receivable Change -18.27 % -4.58 % -9.59 % 51.62 % 1.55 %
Seq. Revenue Change -19.25 % -7.1 % -14.21 % 76.46 % 1.97 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 21
Healthcare Sector # 306
Overall Market # 3229

Receivable Turnover Ratio Statistics
High Average Low
3.67 3.67 3.67
(Sep 30 2014)  





IVD Company Profile • Back to IVD Efficiency Comparisons • Compare IVD Receivables Turnover Ratio to its Competitors

Financial Statements
Erba Diagnostics's Accounts Receivable $ 6 Millions Visit IVD's Balance sheet
Erba Diagnostics's Sales TTM $ 25 Millions Visit IVD's Income Statement
Sources of IVD's Revenues Visit IVD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IVD's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IVD's Growth Rates IVD's Roa IVD's Inventory Turnover Ratio IVD's Dividend Comparisons
IVD's Profitability Ratios IVD's Roi IVD's Asset Turnover Ratio IVD's Dividend Growth
IVD's Valuation Ratios IVD's Roe IVD's Financial Strength Ratios IVD's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2015, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2015 Receivable at quarter ending Mar 31 2015
Ptc Therapeutics inc   10.54 $ 23.510  Millions$ 2.230  Millions
Encision Inc   10.44 $ 9.671  Millions$ 0.927  Millions
Statera Biopharma Inc fka Cytocom Inc   10.42 $ 2.975  Millions$ 0.286  Millions
Quantrx Biomedical Corporation  10.32 $ 0.002  Millions$ 0.000  Millions
Corcept Therapeutics Inc  10.23 $ 32.248  Millions$ 3.152  Millions
Xencor Inc  10.21 $ 8.827  Millions$ 0.864  Millions
Allied Healthcare Products inc   10.11 $ 36.146  Millions$ 3.576  Millions
Strata Skin Sciences Inc  9.97 $ 0.899  Millions$ 0.090  Millions
Intelgenx Technologies Corp   9.90 $ 2.062  Millions$ 0.208  Millions
Nephros Inc   9.89 $ 1.819  Millions$ 0.184  Millions
Amphastar Pharmaceuticals Inc   9.88 $ 221.477  Millions$ 22.427  Millions
Davita Inc   9.80 $ 15,212.946  Millions$ 1,552.331  Millions
Insys Therapeutics, Inc.  9.78 $ 248.181  Millions$ 25.377  Millions
Nrc Health  9.37 $ 99.077  Millions$ 10.574  Millions
Tandem Diabetes Care Inc   9.35 $ 53.965  Millions$ 5.771  Millions
Dynatronics Corporation  9.31 $ 28.267  Millions$ 3.035  Millions
Ibio inc   9.27 $ 1.740  Millions$ 0.188  Millions
Genmark Diagnostics Inc   9.26 $ 32.788  Millions$ 3.543  Millions
Dyne Therapeutics Inc   9.25 $ 2,431.000  Millions$ 262.750  Millions
Prestige Consumer Healthcare Inc   9.23 $ 714.623  Millions$ 77.448  Millions
Antares Pharma Inc   9.08 $ 29.648  Millions$ 3.264  Millions
Supernus Pharmaceuticals inc   9.07 $ 142.136  Millions$ 15.674  Millions
Henry Schein Inc   9.06 $ 10,404.877  Millions$ 1,148.526  Millions
American Bio Medica Corporation  9.03 $ 6.744  Millions$ 0.746  Millions
Dynavax Technologies Corporation  8.93 $ 8.161  Millions$ 0.914  Millions
Idexx Laboratories Inc  8.90 $ 1,508.081  Millions$ 169.430  Millions
Reflect Scientific Inc  8.80 $ 1.439  Millions$ 0.164  Millions
Spero Therapeutics Inc   8.77 $ 13.209  Millions$ 1.506  Millions
Myriad Genetics Inc   8.74 $ 721.980  Millions$ 82.627  Millions
Star Equity Holdings Inc   8.73 $ 56.450  Millions$ 6.466  Millions

Date modified: 2026-08-30T23:41:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.